LCM
TXG icon

Landscape Capital Management’s 10x Genomics TXG Stock Holding History

Landscape Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28M Buy
107,216
+55,717
+108% +$1.11M 0.14% 221
2025
Q4 		$840K Sell
51,499
-19,570
-28% -$296K 0.06% 390
2025
Q3 		$831K Buy
+71,069
New +$927K 0.05% 393
2019
Q4 		– Sell
-17,676
Closed -$891K – 830
2019
Q3 		$891K Buy
+17,676
New +$978K 0.07% 295

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landscape Capital Management's TXG Position: Q1 2026 in Review

Landscape Capital Management increased its 10x Genomics (TXG) stake by 108% in Q1 2026, buying an estimated $1.11M and bringing the position to 107,216 shares worth $2.28M. The position accounts for 0.14% of the portfolio, ranked #221.

Landscape Capital Management first reported a position in TXG in Q3 2019 and has held it in 4 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Landscape Capital Management held 107,216 shares of 10x Genomics worth $2.28M as of Q1 2026.
  • Landscape Capital Management bought 55,717 10x Genomics shares in Q1 2026, an estimated $1.11M.
  • 10x Genomics made up 0.14% of Landscape Capital Management's portfolio in Q1 2026, its #221 holding.
  • Landscape Capital Management first reported a position in 10x Genomics in Q3 2019 and has held it in 4 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.